Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
46.0%
% of FTXH's 51 holdings also in BBP
37.7%
% of BBP's 65 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.9% | 2.1% | 2.1% |
|
AMGEN INC | 3.8% | 2.0% | 2.0% |
|
EXELIXIS INC | 2.1% | 1.8% | 1.8% |
|
BIOGEN IDEC INC | 3.6% | 1.6% | 1.6% |
|
HALOZYME THERAPEUTICS INC | 1.6% | 2.1% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to BBP
|
JOHNSON & JOHNSON | 8.1% |
|
MERCK & CO. INC. | 7.1% |
|
PFIZER INC | 7.1% |
|
ABBVIE INC | 7.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% |
|
ELI LILLY & CO | 3.9% |
|
ZOETIS INC | 3.8% |
|
VIATRIS, INC. | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
UNITED THERAPEUTICS CORP | 2.3% |
FTXH Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
BEIGENE LTD. SPONSORED ADR | -2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
BRIDGEBIO PHARMA, INC. | -1.9% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
DYNAVAX TECHNOLOGIES CORP | -1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | -1.7% |
|
MIRUM PHARMACEUTICALS, INC. | -1.7% |